Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Ly1 Antibody Reactive (LYAR) (Middle Region) Peptid

LYAR Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN979660

Kurzübersicht für Ly1 Antibody Reactive (LYAR) (Middle Region) Peptid (ABIN979660)

Target

LYAR (Ly1 Antibody Reactive (LYAR))

Spezies

Human

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-LYAR antibody (Catalog #: ARP57042_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    LYAR (Ly1 Antibody Reactive (LYAR))

    Substanzklasse

    Antibody

    Hintergrund

    The function of this protein remains unknown.

    Alias Symbols: FLJ20425, ZLYAR

    Protein Interaction Partner: ZBTB16,ZHX1,BRIX1,DDX21,DDX27,DHX57,DHX9,EBNA1BP2,EIF3I,GNL2,GTPBP4,KPNA1,KRT31,KRT82,KRT85,MYBBP1A,NAT10,NPM1,RPL18A,RPL21,RPL23A,RPL3,RPL31,RPS3A,RPS9,Rrp1b,SRP14,TSR1,TWF2,ZBTB16,ZHX1

    Protein Size: 379

    Molekulargewicht

    44 kDa

    Gen-ID

    55646

    NCBI Accession

    NM_017816, NP_060286

    UniProt

    Q9NX58
Sie sind hier:
Chat with us!